MRSN
USDMersana Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$9.065
Haut
$9.065
Bas
$8.000
Volume
0.03M
Fondamentaux de l'Entreprise
Capitalisation Boursière
40.7M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.07M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Truist Securities Maintains Buy on Mersana Therapeutics, Adjusts Price Target To $36 from $250
Truist Securities analyst Asthika Goonewardene maintains Mersana Therapeutics with a Buy, Adjusts Target to $36 from $250
Guggenheim Maintains Buy on Mersana Therapeutics, Lowers Price Target to $30
Guggenheim analyst Michael Schmidt maintains Mersana Therapeutics with a Buy and lowers the price target from $125 to $30.
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC)Plan to report initial clinical data from Emi-Le expansion
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers
Actions Connexes
XLO
Xilio Therapeutics Inc.
STOK
Stoke Therapeutics Inc.
GJO
Synthetic Fixed-Income Securities Inc. on behalf of STRATS(SM) Trust for Wal-Mart Stores Inc. Securities Series 2004-5
CNO
CNO Financial Group Inc.
BCYC
Bicycle Therapeutics plc American Depositary Shares
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.